Connor, Clark & Lunn Investment Management (CC&L)
USNA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Usana Health Sciences USNA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Sell
17,182
-12,879
-43% -$242K ﹤0.01% 1457
2026
Q1 		$525K Sell
30,061
-54,221
-64% -$1.08M ﹤0.01% 1308
2025
Q4 		$1.65M Sell
84,282
-39,043
-32% -$810K ﹤0.01% 974
2025
Q3 		$3.4M Buy
123,325
+25,788
+26% +$794K 0.01% 695
2025
Q2 		$2.98M Buy
97,537
+65,268
+202% +$1.85M 0.01% 735
2025
Q1 		$870K Buy
+32,269
New +$1.02M ﹤0.01% 999
2020
Q4 		– Sell
-4,923
Closed -$363K – 1047
2020
Q3 		$363K Sell
4,923
-14,680
-75% -$1.18M ﹤0.01% 764
2020
Q2 		$1.44M Sell
19,603
-15,590
-44% -$1.22M 0.01% 525
2020
Q1 		$2.03M Buy
+35,193
New +$2.45M 0.02% 414
2019
Q3 		– Sell
-8,925
Closed -$709K – 1095
2019
Q2 		$709K Buy
8,925
+150
+2% +$11.9K ﹤0.01% 650
2019
Q1 		$736K Buy
+8,775
New +$916K ﹤0.01% 594
2018
Q2 		– Sell
-18,400
Closed -$1.58M – 1103
2018
Q1 		$1.58M Sell
18,400
-4,150
-18% -$321K 0.01% 422
2017
Q4 		$1.67M Buy
22,550
+16,250
+258% +$1.09M 0.01% 447
2017
Q3 		$364K Buy
+6,300
New +$372K ﹤0.01% 675
2016
Q3 		– Sell
-4,200
Closed -$234K – 921
2016
Q2 		$234K Sell
4,200
-3,600
-46% -$217K ﹤0.01% 717
2016
Q1 		$474K Sell
7,800
-4,800
-38% -$283K ﹤0.01% 580
2015
Q4 		$805K Buy
12,600
+1,000
+9% +$64.9K 0.01% 474
2015
Q3 		$777K Sell
11,600
-5,200
-31% -$368K 0.01% 447
2015
Q2 		$1.15M Buy
+16,800
New +$1.07M 0.01% 315

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s USNA Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Usana Health Sciences (USNA) stake by 43% in Q2 2026, selling an estimated $242K and leaving 17,182 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in USNA in Q2 2015 and has held it in 19 quarters since. The position peaked at $3.4M in Q3 2025. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 17,182 shares of Usana Health Sciences worth $367K as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 12,879 Usana Health Sciences shares in Q2 2026, an estimated $242K.
  • Usana Health Sciences made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1457 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Usana Health Sciences in Q2 2015 and has held it in 19 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Usana Health Sciences position peaked at $3.4M in Q3 2025.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.